Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-14-002874

Director bought 300,000 shares at $2.44 ($730,500)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS LP · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-05-08 Purchase : show line 1 in the form +300,000 $2.44 $730,500 12,122,262 D
2014-05-08 Purchase : show line 2 in the form +0 12,122,262 I
Open-market purchases · 300,000 sh · avg $2.44 · $730,500
Loading xslF345X03/p1476524.xml…